Overdiagnosis and breast cancer screening

Breast Cancer Research

Volumn 7, Issue 5, 2005, Pages 228-229

  Day, Nick E ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST BIOPSY; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; CARCINOMA IN SITU; COST BENEFIT ANALYSIS; DIAGNOSTIC ERROR; EARLY CANCER; EARLY DIAGNOSIS; EDITORIAL; HEALTH PROGRAM; HUMAN; MASS SCREENING; PROGNOSIS; UNNECESSARY PROCEDURE; UTERINE CERVIX CANCER;

BREAST NEOPLASMS; COMPUTER SIMULATION; FEMALE; HUMANS; MASS SCREENING; REPRODUCIBILITY OF RESULTS;

EID: 25844446216     PISSN: 14655411     EISSN: None     Source Type: Journal    
DOI: 10.1186/bcr1321     Document Type: Editorial

References (5)

1. Moss S: Overdiagnosis and overtreatment of breast cancer: Overdiagnosis in randomised controlled trials of breast cancer screening. Breast Cancer Res 2005, 7:230-234.
2. International Agency for Research on Cancer: IARC Handbooks of Cancer Prevention. Cervix Cancer Screening. Lyon: IARC Press; 2005.
3. Draisma G, Boer R, Otto SJ, van der Cruijsen IW, Damhuis RAM, Schroder FH, de Koning HJ: Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer. J Natl Cancer Inst 2003, 95:868-877.
4. Etzioni R, Penson DF, Legler JM, di Tommaso D, Boer R, Gann PH, Feuer EJ: Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst 2002, 94:981-90.
5. International Agency for Research on Cancer: IARC Handbooks of Cancer Prevention. Breast Cancer Screening. Lyon: IARC Press; 2002.